HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging

Chem Commun (Camb). 2010 Sep 28;46(36):6684-6. doi: 10.1039/c0cc01041c. Epub 2010 Aug 23.

Abstract

We report in this Communication a facile, two-step surface modification strategy to achieve manganese oxide nanoparticles with prominent MRI T1 contrast. In a U87MG glioblastoma xenograft model, we confirmed that the particles can accumulate efficiently in tumor area to induce effective T1 signal alteration.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contrast Media / chemistry*
  • Copper Radioisotopes
  • Humans
  • Magnetic Resonance Imaging*
  • Manganese Compounds / chemistry*
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / ultrastructure
  • Mice
  • Neoplasms, Experimental / diagnosis*
  • Neoplasms, Experimental / diagnostic imaging
  • Oxides / chemistry*
  • Positron-Emission Tomography
  • Serum Albumin / chemistry*
  • Transplantation, Heterologous

Substances

  • Contrast Media
  • Copper Radioisotopes
  • Manganese Compounds
  • Oxides
  • Serum Albumin
  • manganese oxide